APAC ovarian cancer drug market to grow modestly'

Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 m...

January 30, 2015 | Friday | Analysis
Deal with Janssen gets Astellas $65 million up-front

Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to...

October 2, 2012 | Tuesday | News
Lorcaserin receives positive vote from FDA advisory committee

Singapore: Eisai announced that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory C...

April 24, 2012 | Tuesday | News
Biodiem gets US patent allowance for antifungal therapy

Singapore: Australian infectious disease therapy and vaccine development company BioDiem has received notice of Allowanc...

April 24, 2012 | Tuesday | News
Minoryx Therapeutics receives Orphan Drug Designation for its lead candidate MIN-102

Minoryx Therapeutics, a drug development company specialized in the discovery and development of new drugs for orphan di...

February 22, 2017 | Wednesday | News
Apollo Therapeutics launched the first drug discovery programme

Apollo Therapeutics, the collaborative venture between three world-leading UK universities and three global pharmaceutic...

February 22, 2017 | Wednesday | News
New CoolPal Vertos Advance launched by Pelican BioThermal

US based Pelical BioThermal which is a global leader providing the broadcast and most innovative range of temperature-co...

January 19, 2017 | Thursday | News
According to GBI Research, the growth will primarily be driven by the emergence of novel therapeutics

Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, an...

January 19, 2017 | Thursday | News